AV

Albany Ventures Fund III

Europe, Edinburgh, City of, United Kingdom, Edinburgh

Description

Albany Ventures Fund III specializes in managing early stage venture capital and trade investments.

Investor Profile

Albany Ventures Fund III has made 5 investments, with 0 in the past 12 months and 40% as lead.

Stage Focus

  • Series B (40%)
  • Series Unknown (40%)
  • Series C (20%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Medical
  • Biotechnology
  • Developer Platform
  • Software
  • Enterprise Software
  • Saas
  • Health Care
  • Professional Services
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Albany Ventures Fund III frequently co-invest with?

Elaia
Europe, Ile-de-France, France, Paris
Co-Investments: 1
YFM Equity Partners
Europe, England, United Kingdom, London
Co-Investments: 2
ABN AMRO Fund
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
H
Europe, Milton Keynes, United Kingdom, Milton Keynes
Co-Investments: 1
Noble Fund Managers
Europe, England, United Kingdom, London
Co-Investments: 1
SMH Venture Finance Limited
Europe, England, United Kingdom, London
Co-Investments: 1
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 1
Alliance Trust
Europe, Dundee City, United Kingdom, Dundee
Co-Investments: 1
Carvest Crédit Agricole Régions Investissement
Europe, Rhone-Alpes, France, Lyon
Co-Investments: 1
Foresight Group
Europe, England, United Kingdom, London
Co-Investments: 1

What are some of recent deals done by Albany Ventures Fund III?

Mtivity

London, England, United Kingdom

Mtivity provides Web-based marketing and print management solutions for marketing departments and studio managers.

Enterprise SoftwareSaaSSoftware
Series CJul 23, 2007
Amount Raised: $7,080,000
Xention

Pampisford, Cambridgeshire, United Kingdom

Xention Limited is a biopharmaceutical company specialized in the discovery and development of ion channel-modulating drugs.

BiotechnologyDeveloper PlatformMedical
Series BJul 18, 2005
Amount Raised: $13,270,664
High Integrity Solutions

Romsey, Hampshire, United Kingdom

High Integrity Solutions offers compliance-orientated systems and software environments.

Software
Series BJun 16, 2005
Amount Raised: $4,555,410
Digital-Healthcare

Leeds, Leeds, United Kingdom

Digital Healthcare is a health care company.

Health CareMedicalProfessional Services
Series UnknownJun 5, 2005
Amount Raised: $5,446,415
Xention

Pampisford, Cambridgeshire, United Kingdom

Xention Limited is a biopharmaceutical company specialized in the discovery and development of ion channel-modulating drugs.

BiotechnologyDeveloper PlatformMedical
Series UnknownSep 10, 2003
Amount Raised: $6,360,706